Summary
To study long-term effects of captopril on renal function in patients with various forms of severe hypertension, serum creatinine values were monitored in 76 patients under captopril therapy over a period of up to 3 years. Three different groups were formed: (1) patients with essential hypertension (n=37); (2) patients with renovascular hypertension (n=20); (3) patients with renal parenchymatous hypertension (n=19). In each of the three groups reduction in blood pressure was accompanied by increases in serum creatinine. However, both changes were more pronounced in patients with renovascular hypertension. In this group only the rise in creatinine was statistically significant and showed a slight progression with duration of captopril treatment. Group specific analysis revealed that the increase was smaller in patients with unilateral (n=16) renovascular disease than in those with bilateral (n=4) involvement, but in the former it was still significantly higher than in patients with essential or renal parenchymatous hypertension. Separation of patients according to the underlying disease of renovascular hypertension showed that renal function deteriorated less in patients with arteriosclerotic origin (n=10) than in those with fibromuscular dysplasia (n=8). Statistical evaluation of subjects with renovascular and essential hypertension still revealed significant differences in creatinine when the patients with initial plasma renin activity (PRA) below and above 6 ng/ml·3 h were compared separately. A significant correlation (r=0.73;P<0.05) between blood pressure reduction and creatinine changes was obtained only for patients with renovascular hypertension. Finally, in all three groups of patients creatinine changes were statistically independent from daily dosages of captopril. From these data we conclude that sustained impairment of kidney function by captopril is mainly restricted to patients with renovascular hypertension and possibly results from the combined effects of low renal perfusion pressure and interference with intrarenal regulation of glomerular filtration rate by a postulated angiotensin-II-mediated mechanism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Case DB, Atlas SA, Marion RM, Laragh H (1982) Long-term efficacy of captopril in renovascular and essential hypertension. Am J Cardiol 49:1440–1446
Gavras H, Brunner HR, Turini GA, Kershaw GR, Tift CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN (1978) Antihypertensive effect of the oral angiotensin-converting-enzyme inhibitor SQ 14225 in man. N Engl J Med 298:991–995
Havelka J, Vetter H, Studer A, Greminger P, Lüscher Th, Wollnik S, Siegenthaler W, Vetter W (1982) Acute and chronic effects of the angiotensin-converting-enzyme inhibitor captopril in severe hypertension. Am J Cardiol 49:1467–1474
Forslund T, Borgmastars H, Fyhrquist F (1981) Captopril-associated leucopenia confirmed by rechallenge in a patient with renal failure. Lancet 1:166
Collste P, Haglund K, Lundgren G, Magnusson G, Ostman J (1979) Reversible renal failure during treatment with captopril. Br Med J 2:612–613
Farrow PR, Wilkinson R (1979) Reversible renal failure during treatment with captopril. Br Med J 1:1680
Seedat YK (1980) Nephrotic syndrome from captopril. S Afr Med J 57:390
Grossman A, Eckland D, Price P, Edwards CRW (1980) Captopril: reversible renal failure with severe hyperkalemia. Lancet 1:712
Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, Dustan HP (1983) Inhibition of angiotensin-coverting enzyme in renal-transplant recipients with hypertension. N Engl J Med 308:377–381
Hricik DD, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ (1983) Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308:373–376
Haber E, Koerner T, Page LJ, Klimar B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol 29:1349
Blythe W (1983) Captopril and renal autoregulation. N Engl J Med 308:390–391
Aldigier JC, Plouin PF, Guyene TT, Thibonnier M, Corvol P, Menard J (1982) Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension. Am J Cardiol 49:1447–1452
Meaney TF, Dustan HP, McCormack LJ (1968) Natural history of renal arterial disease. Radiology 91:881–887
Case DB, Atlas SA, Mouradian JA, Fishman RA, Sherman RS, Laragh JH (1980) Proteinuria during long-term captopril therapy. JAMA 244:346–349
Kincaid-Smith P, Whitworth JA, Walter NMA, Dowling JP (1980) Immune complex glomerulopathy and captopril. Lancet 2:37
Hoorntje SJ, Weening JJ, Kallenberg CGM, Donker AOM (1979) Serum-sickness-like syndrome with membranous glomerulopathy in patient on captopril. Lancet 2:1297
Forster RP, Maes JP (1947) Effect of experimental neurogenic hypertension on renal blood flow and glomerular filtration rates in intact denervated kidneys of unanesthetized rabbits with adrenal glands demedullated. Am J Physiol 150:534–540
Myers BD, Been WM, Brenner BM (1975) Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101–110
Hall JE, Guyton AC, Cowley AW Jr (1977) Dissociation of renal blood flow and filtration rate autoregulation by renin depletion. Am J Physiol 232:F215–221
Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC (1977) Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366–372
Moore TJ, Crantz FR, Holenberg NK et al. (1981) Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 3:168–73
Hollenberg NK, Swartz SL, Passan DR, Williams GH (1979) Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. N Engl J Med 301:9–12
Dean RH, Kieffer RW, Smith BM, Oates JA, Nadeau JHJ, Hollifield JW, DuPont WD (1981) Renovascular hypertension. Arch Surg 116:1408–1415
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. W. Siegenthaler on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Vetter, W., Wehling, M., Foerster, E.C. et al. Long-term effect of captopril on kidney function in various forms of hypertension. Klin Wochenschr 62, 731–737 (1984). https://doi.org/10.1007/BF01725707
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01725707